These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 7094929)
1. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man. Niederwieser A; Curtius HC; Wang M; Leupold D Eur J Pediatr; 1982 Mar; 138(2):110-2. PubMed ID: 7094929 [TBL] [Abstract][Full Text] [Related]
2. Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain. Kaufman S; Kapatos G; McInnes RR; Schulman JD; Rizzo WB Pediatrics; 1982 Sep; 70(3):376-80. PubMed ID: 7110811 [TBL] [Abstract][Full Text] [Related]
4. Neopterin and biopterin levels in patients with atypical forms of phenylketonuria. Nixon JC; Lee CL; Milstien S; Kaufman S; Bartholomé K J Neurochem; 1980 Oct; 35(4):898-904. PubMed ID: 7452296 [TBL] [Abstract][Full Text] [Related]
5. Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis. Schaub J; Däumling S; Curtius HC; Niederwieser A; Bartholomé K; Viscontini M; Schircks B; Bieri JH Arch Dis Child; 1978 Aug; 53(8):674-6. PubMed ID: 708106 [TBL] [Abstract][Full Text] [Related]
6. Atypical phenylketonuria due to biopterin deficiency. Early treatment with tetrahydrobiopterin and neurotransmitter precursors, trials of monotherapy. Endres W; Niederwieser A; Curtius HC; Wang M; Ohrt B; Schaub J Helv Paediatr Acta; 1982; 37(5):489-98. PubMed ID: 6761317 [TBL] [Abstract][Full Text] [Related]
7. Tetrahydropterin therapy for hyperphenylalaninemia caused by defective synthesis of tetrahydrobiopterin. Kaufman S; Kapatos G; Rizzo WB; Schulman JD; Tamarkin L; Van Loon GR Ann Neurol; 1983 Sep; 14(3):308-15. PubMed ID: 6139056 [TBL] [Abstract][Full Text] [Related]
8. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Niederwieser A; Blau N; Wang M; Joller P; Atarés M; Cardesa-Garcia J Eur J Pediatr; 1984 Feb; 141(4):208-14. PubMed ID: 6734669 [TBL] [Abstract][Full Text] [Related]
9. Tetrahydro-sepiapterin is an intermediate in tetrahydrobiopterin biosynthesis. Milstien S; Kaufman S Biochem Biophys Res Commun; 1983 Sep; 115(3):888-93. PubMed ID: 6354190 [TBL] [Abstract][Full Text] [Related]
11. Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteers. Smith N; Longo N; Levert K; Hyland K; Blau N Mol Genet Metab; 2019 Apr; 126(4):406-412. PubMed ID: 30922814 [TBL] [Abstract][Full Text] [Related]
12. Phenylketonuria with a progressive neurological disorder not responsive to tetrahydrobiopterin. Westwood A; Barr DG Acta Paediatr Scand; 1982 Sep; 71(5):859-61. PubMed ID: 7180460 [No Abstract] [Full Text] [Related]
13. Tetrahydrobiopterin is synthesized by separate pathways from dihydroneopterin triphosphate and from sepiapterin in adrenal medulla preparations. Smith GK; Nichol CA Arch Biochem Biophys; 1983 Nov; 227(1):272-8. PubMed ID: 6639080 [TBL] [Abstract][Full Text] [Related]